Company Filing History:
Years Active: 2025
Title: Jason McLellan: Innovator in Vaccine Development
Introduction
Jason McLellan is a prominent inventor based in Austin, Texas. He is known for his significant contributions to the field of vaccine development, particularly through his innovative work on engineered hMPV F proteins. His research aims to enhance the stability and effectiveness of vaccines, which is crucial in the fight against infectious diseases.
Latest Patents
Jason McLellan holds a patent for "Prefusion-stabilized hMPV F proteins." This patent describes engineered hMPV F proteins that exhibit enhanced conformational stability and antigenicity. The methods outlined in the patent also provide applications for these engineered F proteins in diagnostics, screening platforms, and vaccine compositions. He has 1 patent to his name, showcasing his commitment to advancing medical science.
Career Highlights
McLellan is affiliated with the University of Texas System, where he conducts his research. His work has garnered attention for its potential impact on public health, particularly in the development of effective vaccines. His innovative approach to protein engineering has positioned him as a key figure in the field.
Collaborations
Jason McLellan has collaborated with notable colleagues, including Ching-Lin Hsieh and Scott Rush. These partnerships have furthered his research efforts and contributed to the advancement of vaccine technology.
Conclusion
In summary, Jason McLellan is a dedicated inventor whose work in vaccine development is making a significant impact. His innovative research on engineered hMPV F proteins exemplifies the importance of scientific advancements in public health.